Susquehanna Fundamental Investments LLC Buys 145,158 Shares of CVS Health Co. (NYSE:CVS)

Susquehanna Fundamental Investments LLC raised its stake in CVS Health Co. (NYSE:CVS) by 27.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 665,451 shares of the pharmacy operator’s stock after buying an additional 145,158 shares during the quarter. CVS Health comprises about 0.9% of Susquehanna Fundamental Investments LLC’s portfolio, making the stock its 8th biggest holding. Susquehanna Fundamental Investments LLC owned about 0.05% of CVS Health worth $39,302,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of the stock. Gryphon Financial Partners LLC lifted its position in shares of CVS Health by 48.3% during the fourth quarter. Gryphon Financial Partners LLC now owns 8,151 shares of the pharmacy operator’s stock worth $654,000 after purchasing an additional 2,653 shares in the last quarter. Dorsey & Whitney Trust CO LLC lifted its position in shares of CVS Health by 2.7% during the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 22,944 shares of the pharmacy operator’s stock worth $1,812,000 after purchasing an additional 602 shares in the last quarter. Qtron Investments LLC lifted its position in shares of CVS Health by 26.8% during the fourth quarter. Qtron Investments LLC now owns 7,289 shares of the pharmacy operator’s stock worth $576,000 after purchasing an additional 1,542 shares in the last quarter. Bank of Nova Scotia lifted its position in shares of CVS Health by 306.7% during the fourth quarter. Bank of Nova Scotia now owns 1,008,055 shares of the pharmacy operator’s stock worth $79,593,000 after purchasing an additional 760,166 shares in the last quarter. Finally, Madison Asset Management LLC increased its stake in shares of CVS Health by 17.8% during the fourth quarter. Madison Asset Management LLC now owns 138,850 shares of the pharmacy operator’s stock worth $10,964,000 after buying an additional 21,000 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE CVS opened at $61.38 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The stock has a fifty day moving average price of $58.20 and a 200 day moving average price of $62.05. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The company has a market cap of $77.05 billion, a PE ratio of 10.79, a P/E/G ratio of 0.81 and a beta of 0.53.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same period last year, the company earned $2.21 earnings per share. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. Sell-side analysts forecast that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.33%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio is presently 46.75%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research note on Monday, September 16th. Royal Bank of Canada restated an “outperform” rating and set a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Barclays cut their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. Evercore ISI cut their target price on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. Finally, Wells Fargo & Company upped their target price on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Eleven equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $72.10.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.